Company: NBRG
Filing Date: 2025-08-29
Form Type: S-1
Source: 0001213900-25-082694
Chunk: 158

Company: Newbridge Acquisition Ltd
Filing Date: 2025-08-29
Form: S-1
Chunk 158
---
 Following this offering, the price of our securities may vary significantly due to one or more potential business combinations and general market or economic conditions. Once listed on Nasdaq, an active trading market for our securities may never develop or, if developed, it may not be sustained. Additionally, if our securities become delisted from Nasdaq for any reason, and are quoted on the OTC Bulletin Board, an inter -dealerautomated quotation system for equity securities not listed on a national exchange, the liquidity and price of our securities may be more limited than if we were listed on Nasdaq or another national exchange. You may be unable to sell your securities unless a market can be established and sustained. Once initially listed on Nasdaq, our securities may not continue to be listed on Nasdaq in the future, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. We anticipate that our units will be initially listed on Nasdaq upon consummation of this offering and that the Class A ordinary shares and rights will be listed on Nasdaq once they begin separate trading. However, we cannot assure you of this or that our securities will continue to be listed on Nasdaq in the future. Additionally, in connection with our business combination, Nasdaq will require us to file a new initial listing application and meet its initial listing requirements as opposed to its more lenient continued listing requirements. We cannot assure you that we will be able to meet those initial listing requirements at that time. If Nasdaq delists our securities from trading on its exchange, and we are not able to list our securities on another national securities exchange, we expect our securities could be quoted on an over -the-countermarket. If this were to occur we could face significant material adverse consequences, including: •a limited availability of market quotations for our securities; •a reduced liquidity with respect to our securities; •a determination that our ordinary shares are a “penny stock” which will require brokers trading in our ordinary shares to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for our ordinary shares; •a limited amount of news and analyst coverage for our company; and •a decreased ability to issue additional securities or obtain additional financing in the future. The grant of registration rights to our initial shareholders (including the holders of the representative shares) may make it more difficult to complete our initial business combination, and the future exercise of such rights may adversely affect the market price of our ordinary shares. Pursuant to an